Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study. Journal Of Gastroenterology And Hepatology. https://doi.org/10.1111/jgh.14096 (Original work published 2018)
. (2018).